Pakistan Heart Drug Scare

Officials in Punjab province have arrested the owners of pharmaceutical companies making cardiac drugs suspected to contain heavy-metal contaminants.

By | January 25, 2012

Wikimedia Commons, Ayena

WIKIMEDIA COMMONS, AYENA

As the death toll mounts among patients taking cardiac medications in Pakistan, government officials there have taken steps to stem the fatalities. Details coming out of Lahore, a metropolis at the epicenter of the trouble, are still sketchy, but dozens of patients have reportedly died from taking what are suspected to be heavy metal-laced heart drugs, and thousands more may be at risk. BBC News put the number of dead at 36, citing Pakistani officials, while news sources in the country are reporting anywhere from 27 to 72 deaths.

On Monday (January 23) Pakistan's Federal Investigation Agency arrested the owners of two local pharmaceutical companies that were supplying at least four different cardiac drugs—Cardiovestin (simvastatin), Alfagril (clopidogrel), Concort (amlodipine) and Soloprin (aspirin), according to NewsPakistan—to the Punjab Institute of Cardiology (PIC), which allegedly administered the medications to patients free of cost. Officials have also reportedly sealed off at least one pharmaceutical factory suspected of producing the contaminated drugs.

According to the Daily Times, Punjab provincial Health Secretary Jahanzeb Khan told a news conference on Monday that the PIC had given potentially tainted drugs to 46,000 patients, all of whom would be contacted and advised in the next few days regarding the possible danger to their health. At the same conference, the Daily Times reported, Parliamentary Secretary for Health Saeed Elahi announced that samples of the suspect drugs would be sent to laboratories outside of Pakistan for testing, as the country has no facilities capable of the analyses.

If heavy metals are indeed to blame for the deaths of cardiac patients, it's likely that the contaminants have gotten into their bone marrow and compromised their immune systems or led to dangerous drops in platelet counts, which could result in uncontrolled bleeding. Heavy bleeding was indeed reported in some of the Pakistani victims, according to Reuters.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham